1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;109:102433. doi: 10.1016/j.jaut.2020.102433.
2. Our World in Data. Cumulative COVID-19 tests, confirmed cases and deaths, world Global Change Data Lab; 2021 [cited 2021 October 2nd.]. Available from: https://ourworldindata.org/grapher/covid-tests-cases-deaths?country=~OWID_WRL.
3. Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142.
4. Abdallah SJ, Voduc N, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A, et al. Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19. Ann Am Thorac Soc. 2021. Apr 19. doi: 10.1513/AnnalsATS.202012-1489RL. Online ahead of print.
5. Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. Writing Committee for the Comebac Study Group. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021;325(15):1525-34. doi: 10.1001/jama.2021.3331.
6. Gochicoa-Rangel L, Hernandez-Morales AP, Salles-Rojas A, Madrid-Mejia W, Guzman-Valderrabano C, Gonzalez-Molina A, et al. Gas Exchange Impairment During COVID-19 Recovery. Respir Care. 2021;66(10):1610-17. doi: 10.4187/respcare.09114.
7. Barisione G, Brusasco V. Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19. Physiol Rep. 2021;9(4):e14748. doi: 10.14814/phy2.14748.
8. Ekbom E, Frithiof R, Emilsson O, Larson LM, Lipcsey M, Rubertsson S, et al. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021;182:106394. doi: 10.1016/j.rmed.2021.106394.
9. Nunez-Fernandez M, Ramos-Hernandez C, Garcia-Rio F, Torres-Duran M, Nodar-Germinas A, Tilve-Gomez A, et al. Alterations in Respiratory Function Test Three Months after Hospitalisation for COVID-19 Pneumonia: Value of Determining Nitric Oxide Diffusion. J Clin Med. 2021;10(10):2119. doi: 10.3390/jcm10102119.
10. van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021;73(5):e1089-e98. doi: 10.1093/cid/ciaa1750.
11. Lerum TV, Aalokken TM, Bronstad E, Aarli B, Ikdahl E, Lund KMA, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57(4):2003448. doi: 10.1183/13993003.03448-2020.
12. Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(4):2003690. doi: 10.1183/13993003.03690-2020.
13. Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177-E86. doi: 10.1148/radiol.2021203153.
14. Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481. doi: 10.1183/13993003.03481-2020.
15. Blanco JR, Cobos-Ceballos MJ, Navarro F, Sanjoaquin I, Arnaiz de Las Revillas F, Bernal E, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021;27(6):892-6. doi: 10.1016/j.cmi.2021.02.019.
16. Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021;58(1):2003677. doi: 10.1183/13993003.03677-2020.
17. Shah AS, Wong AW, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76(4):402-4. doi: 10.1136/thoraxjnl-2020-216308.
18. Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163. doi: 10.1186/s12931-020-01429-6.
19. Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020;35(47):e418. doi: 10.3346/jkms.2020.35.e418.
20. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217. doi: 10.1183/13993003.01217-2020.
21. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020;39:101166. doi: 10.1016/j.ctcp.2020.101166.
22. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.
23. Baricich A, Borg MB, Cuneo D, Cadario E, Azzolina D, Balbo PE, et al. Midterm functional sequelae and implications in rehabilitation after COVID-19: a cross-sectional study. Eur J Phys Rehabil Med. 2021; 57(2): 199-207. doi: 10.23736/S1973-9087.21.06699-5.
24. van der Sar-van der Brugge S, Talman S, Boonman-de Winter L, de Mol M, Hoefman E, van Etten RW, et al. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med. 2021;176:106272. doi: 10.1016/j.rmed.2020.106272.
25. Cortes-Telles A, Lopez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021;288:103644. doi: 10.1016/j.resp.2021.103644.
26. Buikema AR, Buzinec P, Paudel ML, Andrade K, Johnson JC, Edmonds YM, et al. Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database. EClinicalMedicine. 2021;39:101075. doi: 10.1016/j.eclinm.2021.101075.
27. St Sauver JL, Lopes GS, Rocca WA, Prasad K, Majerus MR, Limper AH, et al. Factors Associated With Severe COVID-19 Infection Among Persons of Different Ages Living in a Defined Midwestern US Population. Mayo Clin Proc. 2021;96:2528-39. doi: 10.1016/j.mayocp.2021.06.023.
28. Parra-Rodriguez L, Gonzalez-Meljem JM, Gomez-Dantes H, Gutierrez-Robledo LM, Lopez-Ortega M, Garcia-Pena C, et al. The Burden of Disease in Mexican Older Adults: Premature Mortality Challenging a Limited-Resource Health System. J Aging Health. 2020;32(7-8):543-53. doi: 10.1177/0898264319836514.
29. Geneva: WHO. COVID-19 Clinical management: living guidance. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1. Date last accessed: October 11, 2021.
30. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.
31. Elliott J, Whitaker M, Bodinier B, Eales O, Riley S, Ward H, et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS. Med. 2021;18(9):e1003777. doi: 10.1371/journal.pmed.1003777.
32. Vazquez-Garcia JC, Perez-Padilla R, Casas A, Schonffeldt-Guerrero P, Pereira J, Vargas-Dominguez C, et al. Reference values for the diffusing capacity determined by the single-breath technique at different altitudes: The Latin American single-breath diffusing capacity reference project. Respir Care. 2016;61(9):1217-23. doi: 10.4187/respcare.04590.
33. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
34. Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016. doi: 10.1183/13993003.00016-2016.
35. Campbell I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26(19): 3661-75. doi: 10.1002/sim.2832.
36. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B. 1995;57(1):289-300.
37. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324-43. doi: 10.1183/09031936.00080312.
38. Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, et al. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3):1700010. doi: 10.1183/13993003.00010-2017.
39. Toren K, Schioler L, Brisman J, Malinovschi A, Olin AC, Bergstrom G, et al. Restrictive spirometric pattern and true pulmonary restriction in a general population sample aged 50 - 64 years. BMC Pulm Med. 2020;20(1):55. doi: 10.1186/s12890-020-1096-z.
40. Backman H, Eriksson B, Hedman L, Stridsman C, Jansson SA, Sovijarvi A, et al. Restrictive spirometric pattern in the general adult population: Methods of defining the condition and consequences on prevalence. Respir Med. 2016;120:116-23. doi: 10.1016/j.rme